Inactivation of African horse-sickness virus by betapropiolactone and by pH.
The inactivation of several types of African horse sickness virus (AHSV) by pH and by betapropiolactone (BPL) was studied. At 19 degrees - 22 degrees C the virus was stable between pH 6.0 and 10.4, whether suspended in mouse brain or in serumfree buffer. Below pH 5.6 and above pH 10.9, more than 99 per cent of infectivity was inactivated within 15 minutes. The addition of 50 per cent serum did not influence pH stability. Disinfection in the presence of citric acid and caustic soda is briefly discussed. Inactivation by BPL was complete within 30 minutes at 37 degrees C, yet incomplete after 15 hours at 4 degrees C. Types 3 and 9 virus grown in suckling mouse brain and types 1, 3 and 9 produced in pig kidney cells were equally susceptible to 0.1 per cent BPL, more than 99.9 per cent being inactivated. The effectiveness of BPL was reduced at least 10-fold by the addition of 50 per cent serum. No infective virus was detected following incubation of either tissue culture virus with 0.2 per cent BPL or of mouse brain virus with 0.3 per cent BPL. Virus suspensions exposed to 0.3 per cent BPL required buffering with Tris of at least 0.05 molar strength in order to maintain the pH within an acceptable range. Inactivated antigens prepared with 0.4 per cent or lower concentrations of BPL were immunogenic in guinea pigs.
D000356:African Horse Sickness Virus / Q000187:drug effects* / Q000276:immunology / Q000472:pathogenicity; D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D000917:Antibody Formation; D000956:Antigens, Viral; D001921:Brain / Q000382:microbiology; D002460:Cell Line; D006168:Guinea Pigs; D006863:Hydrogen-Ion Concentration; D007274:Injections, Intraperitoneal; D007668:Kidney; D007783:Lactones / Q000494:pharmacology*; D051379:Mice; D009500:Neutralization Tests; D011420:Propiolactone / Q000494:pharmacology*; D012087:Reoviridae / Q000187:drug effects*; D013552:Swine; D013997:Time Factors; D014613:Vaccines, Attenuated / Q000592:standards; D014765:Viral Vaccines / Q000592:standards; D014776:Virus Cultivation
D000914:Antibodies, Viral; D000956:Antigens, Viral; D007783:Lactones; D014613:Vaccines, Attenuated; D014765:Viral Vaccines; D011420:Propiolactone